Modulation of immune responses to vaccination by the microbiota: implications and potential mechanisms
The need for highly effective vaccines that induce robust and long-lasting immunity has
never been more apparent. However, for reasons that are still poorly understood, immune …
never been more apparent. However, for reasons that are still poorly understood, immune …
Fighting the SARS-CoV-2 pandemic requires a global approach to understanding the heterogeneity of vaccine responses
Host genetic and environmental factors including age, biological sex, diet, geographical
location, microbiome composition and metabolites converge to influence innate and …
location, microbiome composition and metabolites converge to influence innate and …
[HTML][HTML] Potential cross-reactive immunity to SARS-CoV-2 from common human pathogens and vaccines
PA Reche - Frontiers in immunology, 2020 - frontiersin.org
The recently emerged SARS-CoV-2 causing the ongoing COVID-19 pandemic is particularly
virulent in the elderly while children are largely spared. Here, we explored the potential role …
virulent in the elderly while children are largely spared. Here, we explored the potential role …
Extension and severity of self-reported side effects of seven COVID-19 vaccines in Mexican population
ME Camacho Moll, AM Salinas Martínez… - Frontiers in public …, 2022 - frontiersin.org
A few studies examined the comparative side effects of Coronavirus Disease-19 (COVID-19)
vaccines. We compared the extension and severity of self-reported side effects of seven …
vaccines. We compared the extension and severity of self-reported side effects of seven …
Side effects following administration of the first dose of Oxford-AstraZeneca's Covishield vaccine in Bangladesh: a cross-sectional study
In response to the raging COVID-19 pandemic, Bangladesh started its vaccine
administration in early 2021; however, due to the rapid development and launch of the …
administration in early 2021; however, due to the rapid development and launch of the …
Pneumococcal and influenza vaccination rates and pneumococcal invasive disease rates set geographical and ethnic population susceptibility to serious COVID-19 …
R Root-Bernstein - Vaccines, 2021 - mdpi.com
This study examines the relationship of pneumococcal vaccination rates, influenza, measles-
mumps-rubella (MMR) diphtheria-tetanus-pertussis vaccinations (DTP), polio, Haemophilus …
mumps-rubella (MMR) diphtheria-tetanus-pertussis vaccinations (DTP), polio, Haemophilus …
Age and sex influence antibody profiles associated with tuberculosis progression
Antibody features vary with tuberculosis (TB) disease state. Whether clinical variables, such
as age or sex, influence associations between Mycobacterium tuberculosis-specific antibody …
as age or sex, influence associations between Mycobacterium tuberculosis-specific antibody …
Predicting vaccine effectiveness against invasive pneumococcal disease in children using immunogenicity data
J Ryman, J Weaver, T Hu, DM Weinberger, KL Yee… - npj Vaccines, 2022 - nature.com
The strength of the immune response, as measured by antibody concentrations, varies
between pneumococcal conjugate vaccines (PCVs). Linking immunogenicity and …
between pneumococcal conjugate vaccines (PCVs). Linking immunogenicity and …
The Ability of Postimmunobiotics from L. rhamnosus CRL1505 to Protect against Respiratory Syncytial Virus and Pneumococcal Super-Infection Is a Strain …
F Raya Tonetti, P Clua, K Fukuyama, G Marcial… - Microorganisms, 2022 - mdpi.com
Previously, we demonstrated that the non-viable strain Lacticaseibacillus rhamnosus
CRL1505 (NV1505) or its purified peptidoglycan (PG1505) differentially modulated the …
CRL1505 (NV1505) or its purified peptidoglycan (PG1505) differentially modulated the …
Immunogenicity following revaccination or sequential vaccination with 23-valent pneumococcal polysaccharide vaccine (PPSV23) in older adults and those at …
AW Cripps, T Folaranmi, KD Johnson… - Expert Review of …, 2021 - Taylor & Francis
Introduction: Immunogenicity studies evaluating sequential administration of pneumococcal
conjugate vaccine (PCV) followed by 23-valent pneumococcal polysaccharide vaccine …
conjugate vaccine (PCV) followed by 23-valent pneumococcal polysaccharide vaccine …